/Companies

Mangrove Therapeutics

Sacramento, US · Founded 2025 · Delaware corporation

Find your way into Mangrove Therapeutics

Sign up to see every warm intro you have to Mangrove Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Mangrove Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

BZ
Benjamin Zhiyi ChenChief Executive Officer (Interim) / President
AS
Alexander Simon GreenChief Financial Officer Treasurer
JL
Jin LiNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$2.5M disclosed across 1 round · 2026

▶$2.5MraisedJul 2026 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jin LiDirector
  • Benjamin Zhiyi ChenExecutive Officer, Director
  • Alexander Simon GreenExecutive Officer
Offering amount
$5M
Amount sold
$2.5M
Minimum investment
$25K
First sale
Jul 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Mangrove Therapeutics raised?
Mangrove Therapeutics has disclosed $2.5M raised across 1 round.
Where is Mangrove Therapeutics headquartered?
Mangrove Therapeutics is headquartered in Sacramento, US.